Clinical Trial Detail

NCT ID NCT01120249
Title S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements no
Sponsors Southwest Oncology Group
Indications

renal cell carcinoma

Therapies

Everolimus

Age Groups: adult

No variant requirements are available.